ARID1A and neoplasm: Furthermore, the analysis of pan-cancer TCGA data revealed a mild but significant correlation where some ARID1A-mutated tumor subtypes present elevated KEAP1 mRNA levels (e.g., stomach adenocarcinoma—STAD, and colon adenocarcinoma—COADREAD) (Figure 3D and Supplementary Figure S3A).